Following this activity, participants should be able to:

Management of Ductal Carcinoma In Situ (DCIS)
•    Assess the risk of recurrence and select optimal treatment strategies for patients with DCIS.
•    Discuss and debate the rationale for adjuvant radiation therapy to treat patients with DCIS.

Adjuvant Radiation Therapy for Early Stage Breast Cancer
•    Recommend individualized radiation therapy based on patient and tumor characteristics of patients with early stage breast cancer.
•    Explore techniques to optimize delivery of radiation therapy and evaluate clinical data supporting regional nodal radiation and alternatives to conventional whole breast radiation therapy.

Surgical Management of the Axilla in Early Stage Breast Cancer, Including SABCS Updates
•    Develop an evidence-based approach for the management of the axilla in patients with early stage breast cancer.
•    Discuss new and emerging data in the treatment of patients with early stage breast cancer and integrate key findings into clinical practice.

Role of Molecular Assays in the Management of Early Stage Breast Cancer
•    List available molecular assays and compare their use in assessment of risk of recurrence.
•    Use molecular assays appropriately to assess risk of recurrence and individualize adjuvant therapy recommendations.

Imaging Studies in Breast Cancer
•    Evaluate the role of various imaging modalities for diagnosis and workup of breast cancer.
•    List clinical indications for the use of breast MRI to diagnose breast cancer.

Adjuvant and Neoadjuvant Therapies for Breast Cancer, Including SABCS Updates
•    Recognize key patient and clinical factors that influence treatment selection for patients with early-stage breast cancer.
•    Select appropriate clinical tools to estimate risk of relapse and the benefits of adjuvant systemic therapy.

Breast Cancer Risk Reduction Strategies
•    Outline the currently available risk reduction strategies for breast cancer.
•    Assist individuals considering chemoprevention in shared decision making by appropriately informing them about the associated risks versus benefits of available therapies.

Late Stage Breast Cancer, Including SABCS Updates
•    Select evidence-based treatment options for patients with advanced hormone-sensitive breast cancer.
•    Compare the risks and benefits of the newer options available for the treatment of patients with HER2-positive disease to limit toxicities and optimize outcomes.